Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2006-09

AUTHORS

Marinos C. Dalakas

ABSTRACT

INTRODUCTION: Although IVIg is highly effective in several autoimmune neuromuscular disorders (neuropathies, myopathies and neuromuscular junction disorders), its effectiveness in autoimmune or neuroinflammatory CNS diseases, with the exception of multiple sclerosis, has not been explored. Emerging data suggest that IVIg may have a role not only in certain antibody-mediated CNS diseases but also in some neurodegenerative disorders associated with "neuroinflammation" mediated by proinflammatory cytokines. METHODS: Data from a previously reported controlled study conducted in patients with stiff person syndrome (SPS) are presented as a paradigm of a CNS disorder associated with specific autoantibodies responding to IVIg. Emerging data using IVIg in various neuroinflammatory and neurodegenerative conditions such as Alzheimers disease, postpolio syndrome (PPS), fibrotic disorders, chronic painful conditions and narcoplepsy are summarized. RESULTS: On the basis of a double-blind placebo-controlled trial conducted in SPS patients with high anti-GAD antibodies, IVIg was shown to be effective resulting in improvement of stiffness and heightened sensitivity scores and increasing the patients' ability to carry out daily activities. In SPS, IVIg also suppressed the anti-GAD antibodies titers probably via an anti-idiotypic effect. A controlled study in patients with PPS, showed reduction in cytokines in serum and CSF with concomitant improvement in the patients' strength and ability to carry out their daily activities. The effect of IVIg in a small number of patients with Alzheimer's disease was promising by reducing the ADAS-cog scores, suggesting a reversal of disease progression. IVIg has been shown to have an effect on tissue fibrosis and in certain subacute painful conditions by suppressing cytokines that mediate fibrosis or pain. In another uncontrolled study, IVIg reduced the number of cataplectic attacks in narcolepsy patients. CONCLUSIONS: IVIg is effective in anti-GAD-positive patients with SPS. Whether it is also effective in other GAD-positive CNS disorders such as epilepsies, cerebellar degenerations or Batten's disease need to be studied in control trials. Emerging data suggest that IVIg, by suppressing proinflammatory cytokines, may exert a beneficial effect in patients with Alzheimer's disease, postpolio syndrome, chronic pain syndromes, fibrotic disorders and narcolepsy. Controlled studies are being planned or conducted to substantiate the benefit of IVIg in neurodegenerative disorders. More... »

PAGES

v25-v32

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00415-006-5004-0

DOI

http://dx.doi.org/10.1007/s00415-006-5004-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023432093

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16998751


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Autoimmune Diseases of the Nervous System", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Central Nervous System Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Immunoglobulins, Intravenous", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Inflammation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neurodegenerative Diseases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Randomized Controlled Trials as Topic", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "National Institute of Neurological Disorders and Stroke", 
          "id": "https://www.grid.ac/institutes/grid.416870.c", 
          "name": [
            "Neuromuscular Diseases Section, NINDS National Institutes of Health, Building 10, Room 4N248, 10 Center Drive MSC, Bethesda, MD 20892-1382, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dalakas", 
        "givenName": "Marinos C.", 
        "id": "sg:person.01126256134.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126256134.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00936885", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000583884", 
          "https://doi.org/10.1007/bf00936885"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.10253", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002556309"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jneuroim.2005.01.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003590244"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1474-4422(06)70447-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007258525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncprheum0140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007448592", 
          "https://doi.org/10.1038/ncprheum0140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncprheum0140", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007448592", 
          "https://doi.org/10.1038/ncprheum0140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jneuroim.2004.01.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007626181"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11940-003-0024-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008671713", 
          "https://doi.org/10.1007/s11940-003-0024-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-005-1105-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014025972", 
          "https://doi.org/10.1007/s00415-005-1105-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00415-005-1105-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014025972", 
          "https://doi.org/10.1007/s00415-005-1105-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/jnnp.62.4.426", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014307304"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200104193441612", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015219114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.pharmthera.2004.04.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015219428"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/brain/awg191", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016291052"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ymgme.2003.11.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017472849"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/brain/awh518", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017883974"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.20339", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019024913"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm0296-148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021497922", 
          "https://doi.org/10.1038/nm0296-148"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.410440209", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021574957"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa01167", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021663698"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-510x(02)00316-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023161505"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)14368-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024170531"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)14368-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024170531"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.55.12.1509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024323630"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1749-6632.1995.tb27543.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027638129"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/brain/awh343", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030042231"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1526-4637.2002.02018.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033045161"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/art.10363", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033097863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0197-4580(00)00124-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034618968"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0022-510x(02)00314-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034899139"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/brain/awh297", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038534520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199005313222202", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038923993"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ana.20400", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039184833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199312303292704", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043499398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.62.6.970", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044533198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-04-0735", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044761676"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.291.19.2367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047418116"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/jnnp.2003.033399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049156215"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archneur.58.2.225", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049365700"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1006/clim.1999.4823", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052493756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00019052-199908000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060292502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00019052-199908000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060292502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00019052-199908000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060292502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00019052-199908000-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060292502"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000039780.13681.ad", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064344833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000039780.13681.ad", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064344833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000039780.13681.ad", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064344833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000145661.01675.a8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000145661.01675.a8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000145661.01675.a8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000145836.72059.3b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346598"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000145836.72059.3b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346598"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000145836.72059.3b", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064346598"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000192129.65677.87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064347734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000192129.65677.87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064347734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000192129.65677.87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064347734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000192129.65677.87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064347734"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000237558.83349.d0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064348529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000237558.83349.d0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064348529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/01.wnl.0000237558.83349.d0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064348529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.44.9.1652", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064372738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.55.1.46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064378711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.55.10.1531", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064378738"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.56.3.323", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.56.3.323", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.56.3.323", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064379430"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.5.780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064380072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.5.780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064380072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1212/wnl.57.5.780", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064380072"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-121-4-199408150-00004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073698948"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-131-7-199910050-00008", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073703596"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4049/jimmunol.175.11.7755", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1077144602"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082852566", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-09", 
    "datePublishedReg": "2006-09-01", 
    "description": "INTRODUCTION: Although IVIg is highly effective in several autoimmune neuromuscular disorders (neuropathies, myopathies and neuromuscular junction disorders), its effectiveness in autoimmune or neuroinflammatory CNS diseases, with the exception of multiple sclerosis, has not been explored. Emerging data suggest that IVIg may have a role not only in certain antibody-mediated CNS diseases but also in some neurodegenerative disorders associated with \"neuroinflammation\" mediated by proinflammatory cytokines.\nMETHODS: Data from a previously reported controlled study conducted in patients with stiff person syndrome (SPS) are presented as a paradigm of a CNS disorder associated with specific autoantibodies responding to IVIg. Emerging data using IVIg in various neuroinflammatory and neurodegenerative conditions such as Alzheimers disease, postpolio syndrome (PPS), fibrotic disorders, chronic painful conditions and narcoplepsy are summarized.\nRESULTS: On the basis of a double-blind placebo-controlled trial conducted in SPS patients with high anti-GAD antibodies, IVIg was shown to be effective resulting in improvement of stiffness and heightened sensitivity scores and increasing the patients' ability to carry out daily activities. In SPS, IVIg also suppressed the anti-GAD antibodies titers probably via an anti-idiotypic effect. A controlled study in patients with PPS, showed reduction in cytokines in serum and CSF with concomitant improvement in the patients' strength and ability to carry out their daily activities. The effect of IVIg in a small number of patients with Alzheimer's disease was promising by reducing the ADAS-cog scores, suggesting a reversal of disease progression. IVIg has been shown to have an effect on tissue fibrosis and in certain subacute painful conditions by suppressing cytokines that mediate fibrosis or pain. In another uncontrolled study, IVIg reduced the number of cataplectic attacks in narcolepsy patients.\nCONCLUSIONS: IVIg is effective in anti-GAD-positive patients with SPS. Whether it is also effective in other GAD-positive CNS disorders such as epilepsies, cerebellar degenerations or Batten's disease need to be studied in control trials. Emerging data suggest that IVIg, by suppressing proinflammatory cytokines, may exert a beneficial effect in patients with Alzheimer's disease, postpolio syndrome, chronic pain syndromes, fibrotic disorders and narcolepsy. Controlled studies are being planned or conducted to substantiate the benefit of IVIg in neurodegenerative disorders.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00415-006-5004-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1014525", 
        "issn": [
          "0340-5354", 
          "1432-1459"
        ], 
        "name": "Journal of Neurology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "253"
      }
    ], 
    "name": "Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects", 
    "pagination": "v25-v32", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "6fa31285f0afe099cefbc6a5367df846b6398d9a47e6aa3962f7547414108aef"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16998751"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0423161"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00415-006-5004-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023432093"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00415-006-5004-0", 
      "https://app.dimensions.ai/details/publication/pub.1023432093"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000373_0000000373/records_13106_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007%2Fs00415-006-5004-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00415-006-5004-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00415-006-5004-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00415-006-5004-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00415-006-5004-0'


 

This table displays all metadata directly associated to this object as RDF triples.

257 TRIPLES      21 PREDICATES      88 URIs      28 LITERALS      16 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00415-006-5004-0 schema:about N73bcd1aef09845658477f41815fcfc91
2 N841cac89fd494c3782a4d294fcdbb4ca
3 Nb3bb0ea4e28d45feb4fcfbe12fc44251
4 Nbd43e63e26d44ec8936b22353661a600
5 Nd7fb785103b54a4c944a56f4f6d747f9
6 Ne9bbeccb607c4f27b3c02c883839cc95
7 Nf46642d44ac14508b1b36b1db39ae066
8 anzsrc-for:11
9 anzsrc-for:1109
10 schema:author N18b523e0b053447bac2f37c86540cd42
11 schema:citation sg:pub.10.1007/bf00936885
12 sg:pub.10.1007/s00415-005-1105-4
13 sg:pub.10.1007/s11940-003-0024-x
14 sg:pub.10.1038/ncprheum0140
15 sg:pub.10.1038/nm0296-148
16 https://app.dimensions.ai/details/publication/pub.1082852566
17 https://doi.org/10.1001/archneur.55.12.1509
18 https://doi.org/10.1001/archneur.58.2.225
19 https://doi.org/10.1001/archneur.62.6.970
20 https://doi.org/10.1001/jama.291.19.2367
21 https://doi.org/10.1002/ana.10253
22 https://doi.org/10.1002/ana.20339
23 https://doi.org/10.1002/ana.20400
24 https://doi.org/10.1002/ana.410440209
25 https://doi.org/10.1002/art.10363
26 https://doi.org/10.1006/clim.1999.4823
27 https://doi.org/10.1016/j.jneuroim.2004.01.010
28 https://doi.org/10.1016/j.jneuroim.2005.01.018
29 https://doi.org/10.1016/j.pharmthera.2004.04.002
30 https://doi.org/10.1016/j.ymgme.2003.11.012
31 https://doi.org/10.1016/s0022-510x(02)00314-3
32 https://doi.org/10.1016/s0022-510x(02)00316-7
33 https://doi.org/10.1016/s0140-6736(03)14368-1
34 https://doi.org/10.1016/s0197-4580(00)00124-x
35 https://doi.org/10.1016/s1474-4422(06)70447-1
36 https://doi.org/10.1046/j.1526-4637.2002.02018.x
37 https://doi.org/10.1056/nejm199005313222202
38 https://doi.org/10.1056/nejm199312303292704
39 https://doi.org/10.1056/nejm200104193441612
40 https://doi.org/10.1056/nejmoa01167
41 https://doi.org/10.1093/brain/awg191
42 https://doi.org/10.1093/brain/awh297
43 https://doi.org/10.1093/brain/awh343
44 https://doi.org/10.1093/brain/awh518
45 https://doi.org/10.1097/00019052-199908000-00006
46 https://doi.org/10.1111/j.1749-6632.1995.tb27543.x
47 https://doi.org/10.1136/jnnp.2003.033399
48 https://doi.org/10.1136/jnnp.62.4.426
49 https://doi.org/10.1158/1078-0432.ccr-04-0735
50 https://doi.org/10.1212/01.wnl.0000039780.13681.ad
51 https://doi.org/10.1212/01.wnl.0000145661.01675.a8
52 https://doi.org/10.1212/01.wnl.0000145836.72059.3b
53 https://doi.org/10.1212/01.wnl.0000192129.65677.87
54 https://doi.org/10.1212/01.wnl.0000237558.83349.d0
55 https://doi.org/10.1212/wnl.44.9.1652
56 https://doi.org/10.1212/wnl.55.1.46
57 https://doi.org/10.1212/wnl.55.10.1531
58 https://doi.org/10.1212/wnl.56.3.323
59 https://doi.org/10.1212/wnl.57.5.780
60 https://doi.org/10.4049/jimmunol.175.11.7755
61 https://doi.org/10.7326/0003-4819-121-4-199408150-00004
62 https://doi.org/10.7326/0003-4819-131-7-199910050-00008
63 schema:datePublished 2006-09
64 schema:datePublishedReg 2006-09-01
65 schema:description INTRODUCTION: Although IVIg is highly effective in several autoimmune neuromuscular disorders (neuropathies, myopathies and neuromuscular junction disorders), its effectiveness in autoimmune or neuroinflammatory CNS diseases, with the exception of multiple sclerosis, has not been explored. Emerging data suggest that IVIg may have a role not only in certain antibody-mediated CNS diseases but also in some neurodegenerative disorders associated with "neuroinflammation" mediated by proinflammatory cytokines. METHODS: Data from a previously reported controlled study conducted in patients with stiff person syndrome (SPS) are presented as a paradigm of a CNS disorder associated with specific autoantibodies responding to IVIg. Emerging data using IVIg in various neuroinflammatory and neurodegenerative conditions such as Alzheimers disease, postpolio syndrome (PPS), fibrotic disorders, chronic painful conditions and narcoplepsy are summarized. RESULTS: On the basis of a double-blind placebo-controlled trial conducted in SPS patients with high anti-GAD antibodies, IVIg was shown to be effective resulting in improvement of stiffness and heightened sensitivity scores and increasing the patients' ability to carry out daily activities. In SPS, IVIg also suppressed the anti-GAD antibodies titers probably via an anti-idiotypic effect. A controlled study in patients with PPS, showed reduction in cytokines in serum and CSF with concomitant improvement in the patients' strength and ability to carry out their daily activities. The effect of IVIg in a small number of patients with Alzheimer's disease was promising by reducing the ADAS-cog scores, suggesting a reversal of disease progression. IVIg has been shown to have an effect on tissue fibrosis and in certain subacute painful conditions by suppressing cytokines that mediate fibrosis or pain. In another uncontrolled study, IVIg reduced the number of cataplectic attacks in narcolepsy patients. CONCLUSIONS: IVIg is effective in anti-GAD-positive patients with SPS. Whether it is also effective in other GAD-positive CNS disorders such as epilepsies, cerebellar degenerations or Batten's disease need to be studied in control trials. Emerging data suggest that IVIg, by suppressing proinflammatory cytokines, may exert a beneficial effect in patients with Alzheimer's disease, postpolio syndrome, chronic pain syndromes, fibrotic disorders and narcolepsy. Controlled studies are being planned or conducted to substantiate the benefit of IVIg in neurodegenerative disorders.
66 schema:genre research_article
67 schema:inLanguage en
68 schema:isAccessibleForFree false
69 schema:isPartOf N286ac7ea92964727924681a34dd16cc8
70 N8375259edbac46d7ba2d31b1a0f5f1c3
71 sg:journal.1014525
72 schema:name Role of IVIg in autoimmune, neuroinflammatory and neurodegenerative disorders of the central nervous system: present and future prospects
73 schema:pagination v25-v32
74 schema:productId N4b6511f4dfdc4521abe2fd4165e4c3e5
75 N4c39a73c8d3c49919c99ef7acedf0fe2
76 N8c5e4969771e4610b1e290941bd57803
77 Ndb2a93d4d19745b4b4445d0f9929015c
78 Nf2bf895093b0422e8e70d850f83d4716
79 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023432093
80 https://doi.org/10.1007/s00415-006-5004-0
81 schema:sdDatePublished 2019-04-11T14:33
82 schema:sdLicense https://scigraph.springernature.com/explorer/license/
83 schema:sdPublisher N7e0c515df56e49c4b984364451a5381f
84 schema:url http://link.springer.com/10.1007%2Fs00415-006-5004-0
85 sgo:license sg:explorer/license/
86 sgo:sdDataset articles
87 rdf:type schema:ScholarlyArticle
88 N18b523e0b053447bac2f37c86540cd42 rdf:first sg:person.01126256134.01
89 rdf:rest rdf:nil
90 N286ac7ea92964727924681a34dd16cc8 schema:volumeNumber 253
91 rdf:type schema:PublicationVolume
92 N4b6511f4dfdc4521abe2fd4165e4c3e5 schema:name dimensions_id
93 schema:value pub.1023432093
94 rdf:type schema:PropertyValue
95 N4c39a73c8d3c49919c99ef7acedf0fe2 schema:name pubmed_id
96 schema:value 16998751
97 rdf:type schema:PropertyValue
98 N73bcd1aef09845658477f41815fcfc91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Humans
100 rdf:type schema:DefinedTerm
101 N7e0c515df56e49c4b984364451a5381f schema:name Springer Nature - SN SciGraph project
102 rdf:type schema:Organization
103 N8375259edbac46d7ba2d31b1a0f5f1c3 schema:issueNumber Suppl 5
104 rdf:type schema:PublicationIssue
105 N841cac89fd494c3782a4d294fcdbb4ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Neurodegenerative Diseases
107 rdf:type schema:DefinedTerm
108 N8c5e4969771e4610b1e290941bd57803 schema:name readcube_id
109 schema:value 6fa31285f0afe099cefbc6a5367df846b6398d9a47e6aa3962f7547414108aef
110 rdf:type schema:PropertyValue
111 Nb3bb0ea4e28d45feb4fcfbe12fc44251 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Inflammation
113 rdf:type schema:DefinedTerm
114 Nbd43e63e26d44ec8936b22353661a600 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Autoimmune Diseases of the Nervous System
116 rdf:type schema:DefinedTerm
117 Nd7fb785103b54a4c944a56f4f6d747f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Immunoglobulins, Intravenous
119 rdf:type schema:DefinedTerm
120 Ndb2a93d4d19745b4b4445d0f9929015c schema:name doi
121 schema:value 10.1007/s00415-006-5004-0
122 rdf:type schema:PropertyValue
123 Ne9bbeccb607c4f27b3c02c883839cc95 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Central Nervous System Diseases
125 rdf:type schema:DefinedTerm
126 Nf2bf895093b0422e8e70d850f83d4716 schema:name nlm_unique_id
127 schema:value 0423161
128 rdf:type schema:PropertyValue
129 Nf46642d44ac14508b1b36b1db39ae066 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Randomized Controlled Trials as Topic
131 rdf:type schema:DefinedTerm
132 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
133 schema:name Medical and Health Sciences
134 rdf:type schema:DefinedTerm
135 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
136 schema:name Neurosciences
137 rdf:type schema:DefinedTerm
138 sg:journal.1014525 schema:issn 0340-5354
139 1432-1459
140 schema:name Journal of Neurology
141 rdf:type schema:Periodical
142 sg:person.01126256134.01 schema:affiliation https://www.grid.ac/institutes/grid.416870.c
143 schema:familyName Dalakas
144 schema:givenName Marinos C.
145 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01126256134.01
146 rdf:type schema:Person
147 sg:pub.10.1007/bf00936885 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000583884
148 https://doi.org/10.1007/bf00936885
149 rdf:type schema:CreativeWork
150 sg:pub.10.1007/s00415-005-1105-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014025972
151 https://doi.org/10.1007/s00415-005-1105-4
152 rdf:type schema:CreativeWork
153 sg:pub.10.1007/s11940-003-0024-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1008671713
154 https://doi.org/10.1007/s11940-003-0024-x
155 rdf:type schema:CreativeWork
156 sg:pub.10.1038/ncprheum0140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007448592
157 https://doi.org/10.1038/ncprheum0140
158 rdf:type schema:CreativeWork
159 sg:pub.10.1038/nm0296-148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021497922
160 https://doi.org/10.1038/nm0296-148
161 rdf:type schema:CreativeWork
162 https://app.dimensions.ai/details/publication/pub.1082852566 schema:CreativeWork
163 https://doi.org/10.1001/archneur.55.12.1509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024323630
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1001/archneur.58.2.225 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049365700
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1001/archneur.62.6.970 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044533198
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1001/jama.291.19.2367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047418116
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1002/ana.10253 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002556309
172 rdf:type schema:CreativeWork
173 https://doi.org/10.1002/ana.20339 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019024913
174 rdf:type schema:CreativeWork
175 https://doi.org/10.1002/ana.20400 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039184833
176 rdf:type schema:CreativeWork
177 https://doi.org/10.1002/ana.410440209 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021574957
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1002/art.10363 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033097863
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1006/clim.1999.4823 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052493756
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/j.jneuroim.2004.01.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007626181
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/j.jneuroim.2005.01.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003590244
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/j.pharmthera.2004.04.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015219428
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/j.ymgme.2003.11.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017472849
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1016/s0022-510x(02)00314-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034899139
192 rdf:type schema:CreativeWork
193 https://doi.org/10.1016/s0022-510x(02)00316-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023161505
194 rdf:type schema:CreativeWork
195 https://doi.org/10.1016/s0140-6736(03)14368-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024170531
196 rdf:type schema:CreativeWork
197 https://doi.org/10.1016/s0197-4580(00)00124-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1034618968
198 rdf:type schema:CreativeWork
199 https://doi.org/10.1016/s1474-4422(06)70447-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007258525
200 rdf:type schema:CreativeWork
201 https://doi.org/10.1046/j.1526-4637.2002.02018.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1033045161
202 rdf:type schema:CreativeWork
203 https://doi.org/10.1056/nejm199005313222202 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038923993
204 rdf:type schema:CreativeWork
205 https://doi.org/10.1056/nejm199312303292704 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043499398
206 rdf:type schema:CreativeWork
207 https://doi.org/10.1056/nejm200104193441612 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015219114
208 rdf:type schema:CreativeWork
209 https://doi.org/10.1056/nejmoa01167 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021663698
210 rdf:type schema:CreativeWork
211 https://doi.org/10.1093/brain/awg191 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016291052
212 rdf:type schema:CreativeWork
213 https://doi.org/10.1093/brain/awh297 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038534520
214 rdf:type schema:CreativeWork
215 https://doi.org/10.1093/brain/awh343 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030042231
216 rdf:type schema:CreativeWork
217 https://doi.org/10.1093/brain/awh518 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017883974
218 rdf:type schema:CreativeWork
219 https://doi.org/10.1097/00019052-199908000-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060292502
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1111/j.1749-6632.1995.tb27543.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1027638129
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1136/jnnp.2003.033399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049156215
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1136/jnnp.62.4.426 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014307304
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1158/1078-0432.ccr-04-0735 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044761676
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1212/01.wnl.0000039780.13681.ad schema:sameAs https://app.dimensions.ai/details/publication/pub.1064344833
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1212/01.wnl.0000145661.01675.a8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064346568
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1212/01.wnl.0000145836.72059.3b schema:sameAs https://app.dimensions.ai/details/publication/pub.1064346598
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1212/01.wnl.0000192129.65677.87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064347734
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1212/01.wnl.0000237558.83349.d0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064348529
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1212/wnl.44.9.1652 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064372738
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1212/wnl.55.1.46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064378711
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1212/wnl.55.10.1531 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064378738
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1212/wnl.56.3.323 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064379430
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1212/wnl.57.5.780 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064380072
248 rdf:type schema:CreativeWork
249 https://doi.org/10.4049/jimmunol.175.11.7755 schema:sameAs https://app.dimensions.ai/details/publication/pub.1077144602
250 rdf:type schema:CreativeWork
251 https://doi.org/10.7326/0003-4819-121-4-199408150-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073698948
252 rdf:type schema:CreativeWork
253 https://doi.org/10.7326/0003-4819-131-7-199910050-00008 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073703596
254 rdf:type schema:CreativeWork
255 https://www.grid.ac/institutes/grid.416870.c schema:alternateName National Institute of Neurological Disorders and Stroke
256 schema:name Neuromuscular Diseases Section, NINDS National Institutes of Health, Building 10, Room 4N248, 10 Center Drive MSC, Bethesda, MD 20892-1382, USA
257 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...